Acta obstetricia et gynecologica Scandinavica
-
Acta Obstet Gynecol Scand · Jan 2006
Randomized Controlled TrialOral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial.
To compare the efficacy of two different dosages of oral misoprostol (50 and 100 microg) with control, in medical induction of labor for patients with prelabor rupture of membranes (PROM) at term. ⋯ Oral misoprostol 50 microg every 4 h is safe, cheap, and as effective as 100 microg in reducing the PROM to delivery time interval and labor duration in primiparous women. The same effect is not observed in a multiparous group.
-
Acta Obstet Gynecol Scand · Jan 2006
Randomized Controlled TrialAcupuncture administered after spontaneous rupture of membranes at term significantly reduces the length of birth and use of oxytocin. A randomized controlled trial.
The objective was to investigate whether acupuncture could be a reasonable option for augmentation in labor after spontaneous rupture of membranes at term and to look for possible effects on the progress of labor. ⋯ Acupuncture may be a good alternative or complement to pharmacological methods in the effort to facilitate birth and provide normal delivery for women with prelabor rupture of membranes.
-
To describe indications for cesarean section for extremely preterm delivery, peri- and postoperative complications and perinatal outcome. ⋯ In balancing the risks of complications related to the surgical procedure against the purported benefits of the infant, this study adds support to the argument to deliver even extremely preterm infants by cesarean section.
-
Acta Obstet Gynecol Scand · Jan 2006
If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
This case-control study was performed to evaluate whether adding first-trimester maternal serum testing to nuchal translucency measurement would improve the antenatal detection of Down's syndrome and decrease the number of women offered fetal karyotyping. ⋯ By adding first trimester biochemistry to nuchal translucency measurement the detection rate of fetuses with Down's syndrome seems to remain unchanged whereas the antenatal risk group to be offered fetal karyotyping decreases.